Cargando…
Circulating tumor DNA in B-cell lymphoma: technical advances, clinical applications, and perspectives for translational research
Noninvasive disease monitoring and risk stratification by circulating tumor DNA (ctDNA) profiling has become a potential novel strategy for patient management in B-cell lymphoma. Emerging innovative therapeutic options and an unprecedented growth in our understanding of biological and molecular fact...
Autores principales: | Lauer, Eliza M., Mutter, Jurik, Scherer, Florian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9417989/ https://www.ncbi.nlm.nih.gov/pubmed/35701522 http://dx.doi.org/10.1038/s41375-022-01618-w |
Ejemplares similares
-
Circulating tumor DNA in Hodgkin lymphoma
por: Maco, Maria, et al.
Publicado: (2022) -
Early assessment of circulating tumor DNA after curative‐intent resection predicts tumor recurrence in early‐stage and locally advanced non‐small‐cell lung cancer
por: Waldeck, Silvia, et al.
Publicado: (2021) -
Bringing circulating tumor DNA to the clinic in Hodgkin lymphoma
por: Kurtz, David M.
Publicado: (2021) -
Circulating Tumor DNA in Gastric Adenocarcinoma: Future Clinical Applications and Perspectives
por: Grizzi, Giulia, et al.
Publicado: (2023) -
Recent translational research: circulating tumor cells in breast cancer patients
por: Müller, Volkmar, et al.
Publicado: (2006)